Sort   by:  
 Page size 
UnknownGenomic diversity of colorectal cancer: Changing landscape and emerging targets.
Improvements in screening and preventive measures have led to an increased detection of early stage colorectal cancers (CRC) where patients undergo treatment with a curative intent. Despite these efforts, a high proportion of patients are diagnosed with advanced stage disease that is associated with...
S-EPMC4932204 | biostudies-literature
UnknownPhase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Purpose No standard treatment exists for patients with cholangiocarcinoma for whom first-line gemcitabine-based therapy fails. Fibroblast growth factor receptor 2 ( FGFR2) fusions/translocations are present in 13% to 17% of intrahepatic cholangiocarcinomas. BGJ398, an orally bioavailable, selective ...
S-EPMC6075847 | biostudies-literature
Sort   by:  
 Page size